Ledger.Open graph →
SEC Form D · Amendment · filed March 18, 2021

Cellix Biosciences, Inc

Offering
$3.0M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Other
Location
NEWARK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Subramaniam Apparsundaram · Newark, NJExec · Director · PromoterMahesh Kandula · Newark, NJDirectorJaideep Khanna · Newark, NJDirectorGretchen Kelly · Portland, ORDirectorKelly Lucas · Portland, ORExec · Director · PromoterPaul K. Etchells · LUXEMBOURG CITY, LuxembourgDirectorKyle F. Gendreau · LUXEMBOURG CITY, LuxembourgExec · Director · PromoterJaideep Khanna · Newark, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗